Bright Minds Biosciences Inc.
DRUG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $605 | $252 | $232 | $231 |
| - Cash | $83 | $51 | $56 | $58 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $522 | $200 | $176 | $173 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$3 | -$3 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$5 | -$3 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.41 | -0.74 | -0.63 | 0.011 |
| % Growth | 44.6% | -17.5% | -5,987.9% | – |
| Operating Cash Flow | -$1 | -$4 | -$2 | -$1 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$1 | -$4 | -$2 | -$1 |